Rosenblatt Securities reissued their buy rating on shares of Arteris (NASDAQ:AIP – Free Report) in a report issued on Friday,Benzinga reports. Rosenblatt Securities currently has a $38.00 target price on the stock.
Several other research analysts have also commented on the company. TD Cowen raised their price objective on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. Northland Securities set a $38.00 target price on Arteris in a research note on Wednesday, May 13th. Jefferies Financial Group raised their target price on Arteris from $16.00 to $35.00 and gave the company a “hold” rating in a report on Wednesday, May 13th. Oppenheimer started coverage on Arteris in a research report on Thursday, July 16th. They set an “outperform” rating and a $40.00 price target on the stock. Finally, Wall Street Zen downgraded shares of Arteris from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Five investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $41.00.
Check Out Our Latest Report on Arteris
Arteris Price Performance
Arteris (NASDAQ:AIP – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The company had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. On average, analysts expect that Arteris will post -0.58 earnings per share for the current year.
Insiders Place Their Bets
In related news, major shareholder Bayview Legacy, Llc sold 26,106 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $31.97, for a total value of $834,608.82. Following the transaction, the insider owned 8,329,071 shares in the company, valued at approximately $266,280,399.87. The trade was a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO K Charles Janac sold 26,106 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $31.97, for a total value of $834,608.82. Following the completion of the transaction, the chief executive officer directly owned 8,329,071 shares of the company’s stock, valued at $266,280,399.87. This represents a 0.31% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,498,949 shares of company stock valued at $52,200,293 in the last three months. 23.30% of the stock is owned by insiders.
Institutional Trading of Arteris
A number of hedge funds have recently made changes to their positions in the stock. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Arteris in the second quarter worth $53,000. Versant Capital Management Inc boosted its stake in Arteris by 33.7% during the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after acquiring an additional 290 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Arteris during the 2nd quarter worth $32,000. State of Wyoming acquired a new position in Arteris during the 2nd quarter worth $165,000. Finally, Royal Bank of Canada increased its position in shares of Arteris by 366.7% in the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock worth $66,000 after purchasing an additional 3,161 shares during the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris News Summary
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
- Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
- Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
- Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
- Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
- Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Recommended Stories
- Five stocks we like better than Arteris
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
